Allogeneic Skin Grafts for Burns: Challenges of Rejection and Infection
Allogeneic (donor) skin grafts for burn patients face significant hurdles:
1. Immunological Rejection
Recipient's immune system recognizes donor HLA antigens → cytotoxic T-cell response → graft destruction. Requires immunosuppression (risky in burn patients).
2. Infection Transmission Risk
Viruses (HIV, HCV, HBV, CMV), bacteria, fungi. Screening reduces but doesn't eliminate risk.
3. Limited Availability
Donor skin scarce; HLA matching further restricts supply. Skin banks help but cannot meet acute massive burn needs.
4. Ethical Concerns
Consent, procurement equity, potential exploitation of vulnerable donors.
5. Surgical Complexity
Technically demanding; risks of bleeding, infection, scarring, contracture.
Current Standard
Autologous grafts (patient's own skin) are gold standard—no rejection, lower infection risk. Allogeneic/xenogeneic grafts or synthetic/biologic temporizing matrices (e.g., Integra) are used as temporary coverage until autograft sites heal for reharvest.
Burns - Related Articles
- Iron Burn Treatment: First Aid & Aftercare
- Effective Burn Scar Treatment Options & Recovery
- Freon (Refrigerant) Burns: Immediate Medical Emergency — Do Not Self-Treat
- Rope Burn Risks and Prevention When Climbing
- Protect Your Lips: Preventing Sunburn & Keeping Them Healthy
- Burning Treated Pine Safely: Precautions & Hazards
- Second-Degree Burns: Appearance, Symptoms & Urgent Care Guidance
